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The Role of Efficacy vs. Effectiveness Research in Evaluating
Psychotherapy
Falk Leichsenring1 & Sven Rabung
Abstract
A sound base of evidence for different kinds of psychotherapy is a
fundamental prerequisite for adequate access to treatment. The present
article addresses the question of what kind of evidence is required to
demonstrate that a specific method of psychotherapy works. Referring to
recent conceptualisations of the logical structure of scientific theories, the
authors argue that randomised controlled trials (RCTs) and effectiveness
studies refer to different domains of intended applications. In RCTs the efficacy
of a treatment under controlled experimental conditions is tested, whereas in
effectiveness studies the outcome of a treatment under the conditions of
clinical practice is examined. Accounting for the different domains of intended
applications has several important implications. These implications refer to
methodological questions of research (e.g. internal and external validity, study
design type), but also the possibility of transferring results from experimental to
field settings, and the criteria for evaluating the evidence-base of treatments.
They also address the important question of the degree to which the presently
available forms of psychotherapy can be regarded as evidence-based. The
considerations presented in this article primarily refer to psychotherapy;
however, they are also relevant to the evidence-based treatment approach in
general.
Key words: Randomised controlled studies, effectiveness studies,
philosophy of science, psychotherapy research, levels of evidence, empirically
supported treatments.
With the recent emphasis on evidence-based medicine (EBM) it is not
surprising that a corresponding approach has reached the field of
psychotherapy. A prominent example is the empirically supported treatment
(EST) approach of the Task Force of Division 12 (Clinical Psychology) of the
American Psychological Association (APA) (Chambless & Hollon 1998;
Chambless & Ollendick 2001; Task Force on Promotion and Dissemination of
Psychological Procedures 1995). The EST approach has been much
discussed with regard to whether it is appropriate for psychotherapy (Beutler
1998; Fonagy 1999; Leichsenring 2004; Persons & Silberschatz 1998; Roth &
Parry 1997; Rothwell 2005; Seligman 1995; Westen, Novotny, & Thompson-
Brenner 2004). The present paper addresses this question in a novel way. The
evidence available for different psychotherapeutic methods is highly relevant
to the question of which treatments are recommended for which patients.
Levels of Evidence
Several methods have been proposed for grading the available evidence of
both
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medical and psychotherapeutic treatments (Canadian Task Force on the
Periodic Health Examination 1979; Chambless and Hollon 1998; Clark &
Oxman 2003; Cook et al. 1995; Guyatt et al. 1995; Nathan & Gorman 2002;
National Institute of Clinical Excellence 2002). Despite some differences, all
available proposals regard RCTs (efficacy studies) as the "gold standard" for
demonstrating that a treatment is efficacious. For example, according to the
APA’s criteria for an EST, at least two RCTs (or controlled single-case
experiments or equivalent time-samples designs) from independent research
groups are required in which a therapy group is significantly superior to a no-
treatment group, placebo group, an alternative treatment or equivalent to an
already established therapy (Chambless & Hollon 1998; Chambless &
Ollendick 2001; Task Force on Promotion and Dissemination of Psychological
Procedures 1995). Furthermore, a treatment manual must be used and a
specific mental disorder must be studied. For the designation of being
efficacious and specific, a treatment must have been shown to be superior to
pill or psychological placebos or to an alternative bona fide treatment in at
least two independent RCTs.
Randomised Controlled Studies and Levels of Evidence
RCTs are conducted under controlled experimental conditions; thus they allow
experimenters to control for variables that may systematically influence the
outcome independent of the treatment. The defining feature of an RCT is the
random assignment of subjects to different conditions of treatment (Shadish,
Cook, & Campbell 2002). Randomisation is regarded as indispensable in order
to ensure that differences between subjects are equally distributed. The goal
of randomisation is to attribute the observed effects exclusively to the applied
therapy. Thus, randomisation is used to ensure the internal validity of a study,
i.e. the validity of inference about whether the observed covariation between
treatment and outcome reflects a causal relationship from treatment to
outcome (Shadish et al. 2002). External validity refers to the question if the
observed relationship between treatment and outcome specified in the
hypothesis under study holds for different patients, therapists, setting and
measures. Within efficacy research the most stringent test is achieved by
comparison with rival treatments, thus controlling for specific and non-specific
therapeutic factors (Chambless & Hollon 1998, p. 8; Gabbard, Gunderson &
Fonagy 2002). Furthermore, such comparisons provide explicit information
regarding the relative benefits of competing treatments. Treatments that are
found to be superior to rival treatments are more highly valued. Gabbard et al.
discuss different types of RCTs that provide different levels of evidence
(Gabbard, Gunderson, & Fonagy 2002). The authors regard RCTs in which a
treatment is compared to a psychological placebo as the second most rigorous
variant within RCTs. However, in our view comparisons with treatments as
usual (TAU) can provide more stringent tests than placebo controlled studies,
because they control for both common factors (e.g. attention) and treatment
effects of TAU. However, a frequent problem in TAU-controlled studies is that
TAU is poorly defined and differs from one study to another. In one study, for
example, TAU may be routine outpatient psychotherapy in clinical practice,
whereas in another study it may be a pure psychopharmacological treatment,
and in a third study it may include counselling or other forms of health care.
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The fourth most rigorous form of RCTs uses waiting list controls. However, in
this type of study, it is not clear if the observed effect in the treatment group is
to be attributed to specific or non-specific therapeutic factors (Gabbard et al.
2002). According to Gabbard et al. (2002), the next level of evidence is
provided by prospective pre-post studies, followed by case series and finally
by case reports.
Critique of the RCT Approach
The EBM and EST approaches, with their emphasis on RCTs, follow the
methodology of pharmacological research. It has been critically discussed
whether this methodology is adequate for psychotherapy research (Beutler
1998; Fonagy 1999; Leichsenring 2004; Persons & Silberschatz 1998; Roth &
Parry 1997; Rothwell 2005; Seligman 1995; Westen, Novotny & Thompson-
Brenner 2004). The main arguments can be summarized as follows: (1) The
defining features of RCTs such as randomisation, use of treatment manuals,
focus on specific mental disorders and frequent exclusion of patients with a
poor prognosis (e.g. multimorbid patients) raise the question as to whether the
results of RCTs are sufficiently representative of clinical practice. (2) Thus, if a
method of psychotherapy has been shown to work under the controlled
conditions of an RCT, this does not necessarily imply that it equally works
under the conditions of clinical practice (Leichsenring, 2004). (3) The EST
approach puts the emphasis on disorders and on symptoms (Blatt 1995). As
Henry (1998, p.129) put it: "EVTs [Empirically Validated Treatments] place the
emphasis on the disorder ... and not on the individual... who seeks our
services." (4) At present, treatment manuals do not exist for multimorbid
patients as they usually occur in clinical practice. The available treatment
manuals refer to the treatment of isolated mental disorders. It is widely
unknown how the treatment of one specific mental disorder (e.g. depressive
disorder) must be modified according to coexisting disorders (e.g. social
phobia or narcissistic personality disorder). (5) The methodology of RCT with
its use of treatment manuals and randomised control conditions is hardly
applicable to long-term psychotherapy lasting several years (Seligman 1995;
Wallerstein 1999). (6) The APA criterion of placebo control groups can be
regarded as questionable (Leichsenring 2004). The concept of placebo
controls (nonspecific or common factor controls) in psychotherapy research is
so conceptually flawed that Lambert and Bergin (1994, p. 152) pleaded, over
10 years ago, to give up placebo controls in psychotherapy research. Placebo
effects in psychotherapy are, in the end, psychotherapeutic effects. (7) From a
methodological perspective, in many RCTs randomisation is only a formal
criterion, and the intended control over confounding variables is probably not
achieved. In order to control for differences between subjects by
randomisation, a sufficient number of subjects is necessary (Hsu 1989). In
many RCTs the sample size is not large enough to achieve equivalent groups
by randomisation (Hsu 1989; Leichsenring & Rabung 2006). For example, in
the meta-analysis by Gloaguen, Cottraux, Cucherat, and Blackburn (1998) of
the efficacy of cognitive therapy in depression, only 38% of the groups had a
sample size of at least 20 patients and only 13% of samples had a size of at
least 40 patients per group, thus fulfilling the criteria for an effective
randomisation as formulated by Hsu (1989). Furthermore, patients frequently
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drop out from control groups, additionally restricting the comparability and
representativeness of the control groups to the treatment group even in RCTs.
Effectiveness Studies
Contrary to RCTs, effectiveness studies are carried out under the conditions of
clinical practice. They are highly representative for clinical practice (Shadish,
Matt, Navarro, & Phillips 2000): patients with complex (i.e. highly comorbid)
disorders (Guthrie 2000), as they usually occur in clinical practice, are treated.
Therapists apply exactly those methods of psychotherapy that they are
accustomed to and experienced in. Patients are referred to the respective
treatments in the standard way of clinical practice, including their own
preferences and decisions regarding a specific kind of therapy or for a specific
psychotherapist. The duration of the treatment is determined by their clinical
requirements (Seligman 1995). Thus, effectiveness studies provide evidence
of the results of a treatment under the conditions of clinical practice. For this
reason, Barkham et al. (2001) and Lucock et al (2003) used the term practice-
based evidence to characterize data from the effectiveness research approach
as contrasted to the evidence-based treatment approach (efficacy data).
These authors have described a systematic approach to generate practice-
based evidence for routine therapy services. The National Institute of Mental
Health in the USA (NIMH) has specifically called for more effectiveness
research (Krupnick et al. 1996). The U.K. Department of Health (1999)
stressed the need for evaluating psychotherapy services in routine service
conditions and the need to compare outcome data from routine clinical practice
with those obtained from RCTs (U.K. Department of Health, 1996).
Limitations of Effectiveness Studies
According to the considerations made above, the strength of effectiveness
studies is their clinical representativeness as they are carried out under
conditions of routine practice. As a consequence, however, effectiveness
studies cannot control for factors affecting the outcome to the same extent as
RCTs (internal validity). Thus, the main argument against effectiveness studies
for demonstrating whether a treatment works refers to possible threats to
internal validity, i.e., to the reduced ability to control factors influencing the
outcome independent of therapy. This is likely to be the reason why
effectiveness studies are not accepted, for example, by the American
Psychological Association as a method for demonstrating that a therapy works.
However, there is evidence that effectiveness studies do not seem to
overestimate effect sizes compared to RCTs. This evidence refers not only to
psychotherapy (Shadish et al. 2000), but also to the broader field of EBM
(Benson & Hartz 2000; Concato, Shah, & Horwitz 2000). For the field of EBM,
Benson and Hartz (2000) and Concato, Shah, and Horwitz (2000) compared
the effects of the same treatment applied to a specific condition found in
effectiveness studies (”observational studies”) with those of RCTs. They did
not find systematic differences. They conclude that there is little evidence that
effect sizes of well-designed effectiveness studies are larger than or
qualitatively different from those found in RCTs. Shadish et al. (2000) rated the
clinical representativeness of selected psychotherapy outcome studies. Non
The Role of Efficacy v Effectiveness Research in Evaluating Psychotherapy
130
randomised studies were rated as significantly more clinically representative.
However, the authors did not find a correlation between clinical
representativeness and effect size. Thus, it can be concluded that non-
randomised studies did not overestimate effect sizes compared to those
obtained in RCTs.2 After all, these findings parallel those reported by Benson
and Hartz (200) and Concato et al (2000).
Philosophy of Science and an Alternative Perspective
Taking more recent developments in the philosophy of science into account, it
has recently been argued that EBM and EST are implicitly based on an
outdated conception of the logical structure of scientific theories (Leichsenring
2004), that being the statement view as the standard conception of scientific
theories (Hempel 1970). The statement view assumes universal validity or
application of a theory. Regarding RCTs as the "gold standard" for
psychotherapy outcome research is implicitly based on the statement view. If,
and only if, a therapy has been proven to work in a controlled research setting
(laboratory) can it then be applied to clinical practice (the field), based on the
assumption that it works equally well in the field.
The statement view of scientific theories can be contrasted with the
structuralist conception of scientific theories (Sneed 1971; Stegmüller 1979;
Westmeyer 1982, 1989). In the structuralist conception of scientific theories
the domain of intended applications is regarded as an integral component of a
theory and the hypotheses derived from it. According to this conception a
theory consists of a theory-core K and a set I of intended applications of K:
"The inclusion of this latter set I into the definition of a theory-element is
characteristic of the structuralist approach. It is a fundamental tenet of
structuralism, that a theory is not universally applicable, but only to a certain
set, range, or domain of intended applications" (Westmeyer 1989, p. 4). In
order to apply a theory, it is necessary to extend the theory-core. This is
achieved by stating hypotheses and special conditions that are valid only for
the intended applications. Therefore, from a structuralist viewpoint, there are
no context-free hypotheses; hypotheses always refer to specific contexts or
intended applications. In RCTs, hypotheses about the efficacy of treatments
under controlled experimental (idealized) conditions are tested; the selection of
patients, therapists, treatments, and outcome measures takes place within a
research project. Thus, in RCTs, laboratory-based hypotheses and
modifications of real-life therapies are tested. For the latter, the term
"laboratory therapies" has been proposed (Leichsenring 2004). In
effectiveness studies hypotheses referring to the conditions of clinical practice
are tested (field hypotheses and "field therapies"). Thus, it depends on the
intended applications whether an efficacy or effectiveness studies is to be
carried out. If the hypothesis under study refers to laboratory contexts, an RCT
is required; if the hypothesis refers to natural conditions, an effectiveness
study is required.
2 Some highly clinically representative non randomised studies rather underestimated the effect
sizes. The authors attribute the smaller effect sizes of these studies to self-selection of more
distressed patients to the treatment group and of the less distressed patients to the control group.
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Thus, from a structuralist viewpoint, controlled and effectiveness studies do not
fundamentally differ in principle concerning their external validity, that is the
degree to which the patients, therapists, treatments, settings and outcome
measures are representative for the conditions specified in the hypothesis
under study, in other words, for the domain of intended applications.
Furthermore, there is no difference between RCTs and effectiveness studies
concerning their internal validity. Extensions of the theory-core and intended
applications in reference to laboratory conditions will lead to simpler
hypotheses and to more rigorous special conditions. In contrast, extensions of
the theory-core and intended applications in reference to field conditions will
have to compensate for reduced experimental control with more liberal special
conditions and correspondingly extended hypotheses. A difference in internal
validity does not arise (for a more detailed discussion see Westmeyer 1982).
Thus, from a structuralist view, RCTs and effectiveness studies do not
fundamentally differ concerning their internal or external validity, and RCTs do
not necessarily provide higher-level evidence than effectiveness studies.
As efficacy studies provide evidence from an intended application different
from clinical practice, empirical evidence from RCTs cannot be directly
transferred to the conditions of the field. If a method of psychotherapy has
been shown to work under laboratory conditions (efficacy), this does not
necessarily imply that it equally works under natural conditions (effectiveness).
There is no justification for an inductive generalization from experimental to
non-experimental conditions of everyday reality (Bredenkamp 1980;
Leichsenring 1985). The effectiveness of a treatment under natural conditions
can be demonstrated only by effectiveness studies. For this reason, the RCTs
listed by the APA (Chambless & Hollon 1998; Chambless & Ollendick 2001) as
empirical support for specific psychotherapeutic methods show only that these
methods work under experimental (laboratory) conditions. That they work
equally well in the field has not yet been demonstrated. One of the main
reasons for the gap between experimental (laboratory) conditions and clinical
practice is that psychotherapy is not a drug that works equally under different
conditions. Difficult-to-quantify factors in the therapist-patient match may
influence outcome. Thus, it is questionable whether the methodology of
pharmacological research is adequate for psychotherapy research of mental
disorders, at least when the effectiveness of a treatment in clinical practice is
to be studied. After all, RCTs serve only a limited function (Roth & Parry 1997).
Levels of Evidence: an Alternative Perspective
Taking into account the different intended applications associated with efficacy
and effectiveness studies, the schemes of levels of evidence which regard
RCTs as the gold standard (Canadian Task Force on the Periodic Health
Examination 1979; Chambless & Ollendick 2001; Cook et al. 1995; Guyatt et
al. 1995; Nathan & Gorman, 2002) refer to treatments under laboratory
conditions (efficacy studies). Thus, they cannot be applied to the question of
whether a therapy works under conditions of routine practice. For effectiveness
studies, which by definition cannot use randomisation, levels of evidence must
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be defined by criteria different from those of efficacy studies.3 For this reason,
it has been proposed that the criteria and levels of evidence for RCTs should
be separated from those for effectiveness studies (Leichsenring 2004).
Levels of Evidence of Effectiveness Studies
For the empirical support of treatments applied in field settings, another
parallel scheme is necessary to describe the levels of evidence in
effectiveness studies. Such a scheme has to take into account the quality of
effectiveness studies. The criteria defining the quality of effectiveness studies
cannot be identical to those of RCTs, although they may overlap. High-level
evidence for the effectiveness of a treatment is provided by high-level
effectiveness studies. By what criteria can high-level effectiveness studies be
defined?
Shadish et al. (2002) have described experimental and quasi-experimental
designs for generalized causal inference. According to Shadish et al. (2002), a
causal inference from a quasi-experimental study must meet three basic
requirements: cause must precede effect, cause must co-vary with effect, and
alternative explanations of the effect must be implausible. As quasi-
experimental studies do not use random assignment, they have to use other
principles to show that alternative explanations of the effect are implausible.
These principles include:
1. The identification and study of plausible threats to internal validity,
2. The use of additional design elements (e.g., observation at more pre-
test time points, additional comparison groups) or of statistical controls, and
3. Coherent pattern matching, that is, prediction of complex patterns of
results (e.g., non-equivalent dependent variables or interactions).
Shadish et al. (2002) discuss several measures of control for different types of
quasi-experimental designs, i.e. for quasi-experimental designs without control
groups or pre-tests or for quasi-experimental designs with control groups and
pre-tests. Due to space limitations, these measures cannot be described here
in detail. A detailed presentation is given by Shadish et al. (2002). The
prediction of differential effects or interactions as a function of different
methods of therapy, different outcome measures or moderator variables may
serve as an example of coherent pattern matching (for the definition of
moderator variables, see Kendall, Holmbeck & Verduin 2004). For example,
the results of cognitive-behavioural therapy of social phobia are modified by
several moderator variables such as the severity of symptoms (Otto et al.
2000), type of social phobia (isolated or general, Hope et al. 1995), comorbid
3 There is only one exception: If a waiting list group is used as a comparison condition,
randomisation can be used in an effectiveness study without affecting the service delivery too
much. Patients as they are usually treated in clinical practice can be randomly assigned to the
treatment or to the waitlist group. I would like to thank one of the anonymous reviewers for
calling our attention to point. - However, for ethical and practical reasons the use of waiting list
comparison groups is only justifiable and applicable for short-term treatments.
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depression (Erwin et al. 2002), and expectations of therapy (Chambless, Tran,
& Glass 1997). When included in a study design, these variables can be
examined with regard to their effects on therapy outcome. The more that the
predicted differential effects occur, the less probable it is that the changes
observed can be attributed to factors other than the method of therapy applied.
Furthermore, according to a recent proposal ‘change norms’ can be used as
additional design elements (Leichsenring & Rabung 2006). Furthermore
process research can contribute to a more stringent conclusion that an
observed effect is associated with the interventions applied. In an open study
of psychodynamic therapy for depression, Hilsenroth et al. (2003) showed that
the observed effects were associated with the defining features of
psychodynamic therapy but not with the defining features of cognitive-
behavioural therapy.
Taking these refined methodological issues into account a proposal has been
made to grade the levels of evidence of effectiveness studies (Leichsenring
2004). According to this proposal, a high-level effectiveness study is a
prospective quasi-experimental study of high clinical representativeness,
characterized by non-random comparison groups, the matching or stratifying of
groups, clear descriptions of treatments, patients and their selection, the use of
reliable and valid diagnostic procedures and outcome measures, the use of
additional design elements, coherent pattern matching, reporting of drop outs,
pre- and post-assessments, follow-up studies, and the reporting of relevant
statistical data. Clinical representativeness is achieved by the selection of
patients, therapists, and treatments that are typical for clinical practice (Wells
1999; Shadish et al. 2000). Plausible threats to internal validity are controlled
for by the use of additional design elements (e.g., observation at more pretest
time points, additional comparison groups), statistical controls, or coherent
pattern matching, that is, prediction of complex patterns of results (e.g., non-
equivalent dependent variables or interactions). According to this definition,
the gold standard of effectiveness studies (effectiveness studies) is a
prospective quasi-experimental study of high clinical representativeness that
fulfills all or at least most of the aforementioned criteria. Lower-level
effectiveness studies differ from high-level studies in one or more of these
aspects (Leichsenring 2004). In order to judge the effectiveness of a method of
therapy (in a specific disorder) in clinical practice, the existing studies have to
be rated with regard to their levels of evidence according to criteria that remain
to be defined. Furthermore, definitions must be given that are similar to those
of the APA guidelines concerning the number of studies regarded as
necessary. For a treatment to be judged as "effective" in clinical practice, at
least two independent level I studies may be regarded as necessary. To be
judged as "probably effective," one level I study may be regarded as
necessary.
Complementary Relationship of Efficacy and Effectiveness Studies
As discussed above, efficacy and effectiveness studies address different
research questions: RCTs examine the efficacy of a treatment under controlled
experimental conditions, whereas effectiveness studies address the
effectiveness under clinical practice conditions. As a consequence, the
relationship between RCTs and effectiveness studies is not competitive;
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rather, it is complementary. From this perspective, a distinction between
empirically supported therapies (EST) and RCT methodology is required
(Leichsenring 2004; Westen, Novotny, & Thompson-Brenner 2004).
Discussion
The present article addresses the discussion of efficacy vs. effectiveness in
psychotherapy outcome research. Considerations from the view of the
philosophy of science have shown that methodological questions cannot be
answered in isolation from content, i.e. from the question of research.
Buchkremer and Klingberg (2001) proposed that the testing of psychotherapy
should be conceptualised as analogous to the testing of pharmacological
treatments. As noted above, the essential argument against such a model is
that psychotherapy is not a drug that works equally under different conditions,
i.e. in the laboratory of a research project and in the field of clinical practice.
The results of social psychology experiments alone (e.g. Rosenthal 1981)
speak against such a model. Contrary to pharmacological research,
interpersonal factors are not only the common, but also the specific curative
factors (e.g., Luborsky 1984; Lambert & Bergin 1994; Orlinsky, Grawe, &
Parks 1994). For this reason, psychotherapy outcome research needs a model
of its own that is appropriate to its subject. Making RCTs an absolute is a
result of the abuse of the drug metaphor in psychotherapy research (Stiles &
Shapiro 1989).
The presently available proposals made to define evidence-based
psychotherapeutic treatments refer to the treatment of a specific mental
disorder (e.g. panic disorder). However, results of epidemiological studies
have shown that most patients do not suffer from an isolated mental disorder
(Kessler et al. 1994; Kessler, Chiu, Demler, & Walters 2005). Rates of
comorbidity are typically high, and most patients are multimorbid. However, as
mentioned above, the treatment manuals presently available describe the
treatment of a specific isolated mental disorder. They do not answer the
question of how to treat, for example, a major depressive disorder associated
with a post-traumatic stress disorder and a narcissistic personality disorder. It
is widely unknown how effective the empirically supported treatments for
depressive disorders, as listed for example by Chambless and Hollon (1998)
or Nathan and Gorman (2002), are in the treatment of highly comorbid
patients. Furthermore, the emphasis on highly structured psychotherapeutic
methods tailored to the treatment of a specific mental disorder corresponds to
a conceptualisation of psychotherapy-like cognitive-behavioural therapy rather
than to other forms of psychotherapy, e.g. psychodynamic therapy. Thus, it is
no surprise that the EST approach was initiated by proponents of CBT
(Chambless and Hollon 1998, Chambless and Ollendick 2001). Furthermore, a
highly structured conceptualisation of psychotherapy seems to correspond to
specific personality traits that were found in CBT therapists rather than in
psychodynamic therapists (Topolinski & Hertel, 2007).
Certainly, the differentiation of randomised controlled (laboratory) studies and
effectiveness studies, on which this article has focused, is not a new idea (e.g.
Seligman 1995; Wells 1999). However, what is new is the pursuit of this
differentiation with regard to the implications that arise from a structuralistic
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view of theories: RCTs and effectiveness studies serve different purposes and
answer different questions of research. Thus, RCTs are required, for example,
if a newly developed method of psychotherapy is to be tested with regard to
specific therapeutic effects. This is especially true if alternative treatments are
available. For example, Crits-Christoph et al. (1999) tested a specialized form
of Luborsky´s psychodynamic therapy for the treatment of cocaine
dependence by comparing it to cognitive-behavioural therapy and drug
counselling. RCTs are also required for the study of isolated elements of
therapy (dismantling strategies, e.g. Borcovec 1993; Jacobson et al. 1996;
Ahn & Wampold 2001). Before a new method of psychotherapy is applied in
clinical practice, it is necessary for both financial and ethical reasons to test its
efficacy in a preliminary step under controlled conditions. On the other hand, if
the effectiveness of a treatment in the field is to be tested, effectiveness
studies of high methodological quality are required. On the other hand, if a
treatment has been shown to work under the conditions of clinical practice, it
does not make sense to test its efficacy under experimental conditions.
We hope that the differentiation of empirical evidence into laboratory vs. field
types of evidence and, respectively, into laboratory therapies vs. field therapies
will be incorporated into psychotherapy research and, thus, in the
conceptualisation of evidence-based psychological therapies. This
differentiation implies that for many psychotherapeutic methods (e.g.
Chambless & Ollendick 2001), there is evidence only that they work under
laboratory conditions. It is widely unknown how effective these methods are in
the field of psychotherapeutic practice. It is only in recent years that
researchers have become aware of this problem. Shadish et al. (2000), for
example, studied the influence of the degree of clinical representativeness of
studies on the outcome of therapy.
From the differentiation into laboratory and field types of evidence, a new
research agenda for effectiveness studies can be derived which is analogous
to that of efficacy studies (Leichsenring 2004). This research addresses how
effective psychotherapeutic methods in specific, though comorbid disorders
(e.g. depression, anxiety disorders, somatoform disorders, highly comorbid
disorders) are in clinical practice. There are at least two different strategies: In
the first, the effectiveness of therapies that are already applied in the field is
evaluated (e.g. Seligman 1995); in the second, psychotherapeutic methods
that had been tested in RCTs are applied and, if necessary, modified in clinical
practice (e.g. Hahlweg, Fiegenbaum, Frank, Schroeder, & von Witzleben
2001). At present, only a few studies of this type for specific disorders exist,
e.g. for panic disorders (Wade, Treat, & Stuart 1998; Hahlweg et al. 2001),
depression (Peterson & Halstead 1998; Persons, Bostrom & Bertagnolli 1999;
Organista, Munoz & Gonzales 1994), bulimia nervosa (Tuschen-Caffier, Pook
& Frank 2001) or for externalising disorders in children and adolescents
(Tynan, Schumann & Lampert 1999). Initial results show, that in routine clinical
practice patients do not profit from specific methods of therapy to the same
extent as was reported from RCTs, that therapies are carried out for a longer
time, or that additional elements of therapy are added, e.g.,
psychopharmacological therapy (Chambles & Ollendick 2001, p. 711). In other
words, the laboratory forms of therapy are not purely applied in clinical
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practice: modified versions are used. These results show that data from
experimental conditions cannot directly be transferred to clinical practice.
The present article explicitly calls for a definition of the criteria that determine
the level of quality of an effectiveness study. By definition, effectiveness
studies cannot use randomisation with the exception of waiting-list comparison
conditions. They have to apply other strategies to ensure internal validity.
According to the extent to which internal, external, and other aspects of validity
are ensured, different effectiveness studies may differ concerning their levels
of evidence. Whereas external validity of effectiveness studies concerning the
treated patients can be ensured relatively easily (e.g. by comparison with
epidemiological data), this is more difficult with regard to therapists. For this
purpose, data of relevant features of therapists are required (Wells 1999).
Internal validity of both effectiveness studies and RCTs can be reduced by
several factors, one being small sample size. With insufficient sample size,
small differences between (nonrandomised) groups in effectiveness studies
are not detected with sufficient power (Wells 1999). In RCTs it is questionable
whether randomisation leads to equivalent groups if the sample size is
insufficient (Hsu 1989). Dropouts can impair the internal validity in both types
of studies. Here, intent-to-treat analyses are required (Wells 1999). Moreover,
there is empirical evidence that randomisation is often incorrectly carried out,
and that non-random manipulations of comparison groups are made (Schulz,
Chalmers, Grimes & Altman 1994). The results presented by Shadish at al.
(2000) are relevant with regard to the appropriateness of effectiveness studies
as methods for testing if a treatment works. Shadish at al. (2000) did not find a
significant correlation between the degree of clinical representativeness (e.g.,
RCTs vs. effectiveness studies) and the size of the effects reported in studies
of psychotherapy. Thus, the conclusion can be drawn that (high-level)
effectiveness studies do not systematically overestimate the effects of
psychotherapy.
The proposal for levels of evidence made in this article can be used in both the
judgment of existing effectiveness studies and planning of new studies. This
proposal is intended to stimulate scientific discussion.
Finally, it should be noted that the differentiation between pure efficacy studies
and pure effectiveness studies is somewhat arbitrary. The distinction between
these two types of study designs can be more blurred than described in this
paper so far (Guthrie. 2000). In RCTs, for example, elements of routine clinical
practice can be implemented (e.g. treatments as they are usually applied in
clinical practice or patients as they usually treated in clinical practice). Also in
effectiveness studies elements of RCTs can be used, for example patients with
specific mental disorders can be included. However, these patients usually
show not only one, but multiple mental disorders. If randomisation is used in a
study carried out under the conditions of clinical practice, the
representativeness for clinical practice is reduced, because patients are not
referred to the treatments by the usual ways of clinical practice including their
own preferences for a specific type of treatment or for an individual therapist –
the one exception was described above. Thus, a continuum may be more
appropriate than a dichotomous distinction between experimental and
effectiveness studies with “pure” RCTs marking the one pole and “pure”
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effectiveness studies marking the other pole. Studies including elements of the
other study type lie in between. Consistent with this mixed model, Hilsenroth et
al. (2003) applied a model that they called (p. 349) a “hybrid
efficacy/effectiveness treatment research model”.
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